-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Louise Batchelor
Group Chief Marketing & Communications Officer
Louise is the Group Chief Marketing and Communications Officer of Volition and has been a valued member of the team since joining in 2016.
Louise is the Group Chief Marketing and Communications Officer of Volition and has been a valued member of the team since joining in 2016. She brings more than 25 years of marketing, sales and leadership experience to her role at Volition. Formerly Louise worked in various roles at Reckitt Benckiser including some overseas posts in Paris and New York in addition to being Director and Owner of Aculd Ltd, a strategic marketing consultancy specializing in healthcare for five years.
Louise holds a Bachelor of Arts in Business Studies from Sheffield Hallam University.
“Our long-term goal drives all of our day-to-day activities. We expect that our product pipeline, when realized, will change people’s lives throughout the world.”
Louise Batchelor
Group Chief Marketing & Communications Officer